Obese patients and association lament weak 15% state subsidy and restricted access to anti-obesity drugs

A newly published ordinance sets a 15% special reimbursement rate for anti-obesity medications under strict conditions: patients must be followed at specific hospital obesity units within local health units (ULS), and prescriptions are limited to endocrinologists, internal medicine doctors, and pediatricians. The Adexo association and family doctors' representatives criticized the scheme for excluding primary care and failing to make the drugs affordable.